Mario Lorenzo
Díaz González
Investigador no período 1995-2020
Eli Lilly and Company
Indianapolis, EE. UU.Publicacións en colaboración con investigadores/as de Eli Lilly and Company (1)
2006
-
The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139